In general, the new strategies for application of interferons are included to the in-vivo use of  IFNα as immune adjuvants of cancer vaccines, and the combination of certain chemotherapies with IFNα adjuvanted cancer vaccines [26]. The gene discussed is IFNA17; the disease is cancer.